Try a single issue or save on a subscription Issues delivered straight to your door or device ...

New research provides guidance on the effects of caffeine, diet and naps on sleep. Plus there are expanded treatments for ...

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Treatment and management of CompSA can be complex. Diagnosis can also be challenging due to similarities in symptoms. While they have different causes and risk factors, all types of sleep apnea ...

Obstructive sleep apnea (OSA) is very common with 15% to 30% of men in the United States and 10% to 15% of women having the ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...